EicOsis
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1930 5th St Ste A, Davis, California, 95...Phone Number
(530) 338-0070Website
www.eicosis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About EicOsis
EicOsis is focused on developing innovative treatments for chronic pain and inflammation by targeting the soluble Epoxide Hydrolase enzyme, aiming to restore the body's natural healing abilities. The company is committed to addressing the urgent need for safe, non-addictive pain medications, particularly in light of the opioid crisis affecting millions in the U.S. Their lead drug candidate is currently undergoing Phase 1 clinical trials, with a focus on providing effective solutions for patients suffering from neuropathic pain and other inflammatory conditions. EicOsis seeks to improve the quality of life for individuals impacted by chronic pain through their novel therapeutic approaches.Explore more
EicOsis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EicOsis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
EicOsis, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when EicOsis launches new products
Click to see if EicOsis had a recent Job posting/layoffs
Earning: See what the market has to say on EicOsis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if EicOsis has recently received funding, and reach out quickly before it becomes old news!
Check out if EicOsis is spiking on competitors!
Funding: Get notified immidiatlly once EicOsis has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at EicOsis
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to EicOsis
Compare insights from companies similar to EicOsis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EicOsis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EicOsis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EicOsis.
EicOsis financials insights
Gather financial insights about EicOsis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$4M
EicOsis Tech Stack
A closer look at the technologies used by EicOsis
See more technologies
EicOsis News & Media
EicOsis Announces the Appointment of Dr. Cindy McReynolds as CEO
Safely treating chronic inflammation while bringing new hope to patients with pain DAVIS, Calif., Feb. 9, 2023 /PRNewswire/ -- EicOsis Human Health is pleased to announce the appointment of Dr. Cindy McReynolds as CEO. Dr. McReynolds will lead EicOsis through the commercialization of its...EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026
DAVIS, Calif., Nov. 17, 2020 /PRNewswire/ -- EicOsis Human Health, a pharmaceutical company developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase (sEH) enzyme, today announced the successful completion of a Phase 1a single-ascending...EicOsis Announces First Subject Dosed in Phase 1a Clinical Trial of EC5026
DAVIS, Calif., Dec. 10, 2019 /PRNewswire/ -- EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase (sEH) enzyme, today announced initiation of dosing for the first human subject in a Phase 1 trial...EicOsis Announces First Subject Dosed in Phase 1a Clinical Trial of EC5026
EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase (sEH) enzyme, today announced initiation of dosing for the first human subject in a Phase 1 trial of EC5026, the company's lead product candidate for pain management. This Phase 1a, singleascending dose trial will evaluate the safety and tolerability of single oral doses of EC5026 in healthy volunteers.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EicOsis
Sign Up For FreeTo access detailed company insights
EicOsis is focused on developing innovative treatments for chronic pain and inflammation by targeting the soluble Epoxide Hydrolase enzyme, aiming to restore the body's natural healing abilities. The company is committed to addressing the urgent need for safe, non-addictive pain medications, particularly in light of the opioid crisis affecting mill... Read More
